Correlation analysis to assess surrogate endpoints for overall survival (OS) in triplenegative breast cancer (TNBC)

被引：0
|
作者：
Perez-Granado, Judith
Kalucha, Ankit
Gala, Kinisha
Bodriagova, Olga
Vidal, Laura
Larvol, Bruno
Gramling, Mark
Saini, Kamal S.
机构：
[1] Larvol Grp LLC, San Francisco, CA USA
[2] LabCorp Drug Dev, Princeton, NJ USA
[3] Labcorp Drug Dev, Burlington, NC USA
[4] Cambridge Univ Hosp NHS Trust, Addenbrookes Hosp, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13089
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer
    Gyawali, Bishal
    D'Andrea, Elvira
    Franklin, Jessica M.
    Kesselheim, Aaron S.
    ECLINICALMEDICINE, 2021, 32
  • [2] A systematic review of surrogate endpoints (SEPs) for overall survival (OS) in metastatic colorectal cancer (mCRC).
    Anand, Seerat
    Tannenbaum, Daniel
    Horn, Robert Asa
    Morris, Van K.
    Johnson, Benny
    Eng, Cathy
    Kopetz, Scott
    Overman, Michael J.
    Raghav, Kanwal Pratap Singh
    Dasari, Arvind
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Surrogate endpoints for overall survival in lung cancer trials: a review
    Fiteni, Frederic
    Westeel, Virginie
    Bonnetain, Franck
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (05) : 447 - 454
  • [4] Review of Meta-analyses Evaluating Surrogate Endpoints for Overall Survival (OS) in Oncology
    Sherrill, B.
    Akhras, K.
    Kaye, J.
    Sandin, R.
    Cappelleri, J.
    Heyes, A.
    Chen, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S261 - S261
  • [5] SURROGATE ENDPOINTS FOR OVERALL SURVIVAL (OS) IN ADVANCED MELANOMA: A TARGETED LITERATURE REVIEW (TLR) OF CORRELATION META-ANALYSES
    Pourrahmat, M. M.
    Leung, L.
    Kurt, M.
    Chou, E.
    Kanters, S.
    Moshyk, A.
    Hamilton, M.
    VALUE IN HEALTH, 2022, 25 (01) : S37 - S37
  • [6] CORRELATION AND PROGNOSTIC VALUE OF SURROGATE ENDPOINTS AND OVERALL SURVIVAL (OS) IN MULTIPLE MYELOMA (MM): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Yucel, E.
    Malcolm, B.
    Diakite, I
    Peterse, E.
    Stewart, A.
    Spoorendonk, J. A.
    VALUE IN HEALTH, 2022, 25 (01) : S26 - S27
  • [7] Surrogate endpoints for overall survival in randomized controlled trials evaluating adjuvant treatment for breast cancer: A meta-analysis
    Savina, M.
    Jacot, W.
    Mathoulin-Pelissier, S.
    Laghzali, Y.
    Bellera, C.
    Gourgou, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Assessing Correlation between Surrogate Endpoints and Overall Survival for Oncology Clinical Trials
    Chu, Guotao
    Zhu, Xiaochen
    Wu, Jiaju
    Tang, Yike
    Luu, Jonathan
    He, Chunsheng
    Huang, Shu-Pang
    Liu, Liangang
    Hsieh, Hsin-Ju
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
  • [9] Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
    Ghali, Fady
    Zhao, Yibai
    Patel, Devin
    Jewell, Teresa
    Yu, Evan Y.
    Grivas, Petros
    Montgomery, R. Bruce
    Gore, John L.
    Etzioni, Ruth B.
    Wright, Jonathan L.
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 47 : 58 - 64
  • [10] Retrospective pooled analysis to assess correlation between time to progression and overall survival in patients with breast cancer
    Sherrill, B.
    Hirst, C.
    Wu, Y.
    Amonkar, M.
    Stein, S. H.
    BREAST, 2007, 16 : S54 - S54
12345